Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Intake of Omega-3 Fatty Acids and the Inhibition of Their Mitochondrial Metabolism Increase EPA and DHA Levels in Healthy Volunteers

NCT07304921 is registered in ClinicalTrials.gov with Riga Stradins University as lead sponsor.

NCT NCT07304921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07304921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Intake of Omega-3 Fatty Acids and the Inhibition of Their Mitochondrial Metabolism Increase EPA and DHA Levels in Healthy Volunteers
Lead sponsor
Riga Stradins University
Phase
Phase 1
Overall status
Completed
Start date
April 6, 2023
Completion date
June 6, 2023
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipid metabolism, omega-3 polyunsaturated fatty acids, supplementation